Hanzhong TRG Biotech Co., Ltd.

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• LACKS FIRM1 refused line

  Manufacturer name and address missing

  The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.

• LACKS N/C1 refused line

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

• SBGINSENG1 refused line

  SBGINSENG

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Hanzhong TRG Biotech Co., Ltd.

Is Hanzhong TRG Biotech Co., Ltd. on an FDA import alert?

Yes. As of October 26, 2026, Hanzhong TRG Biotech Co., Ltd. is on the red list of FDA Import Alert 54-12, “Foods that do not properly declare ginseng”, for siberian ginseng extract; FDA published the listing on December 8, 2020.

Has FDA refused shipments from Hanzhong TRG Biotech Co., Ltd.?

Yes. FDA refused 2 shipment lines from Hanzhong TRG Biotech Co., Ltd. between October 6, 2020 and August 10, 2021. The most recent, on August 10, 2021, was tribulus (herbal & botanicals, not teas), charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Hanzhong TRG Biotech Co., Ltd.'s shipments?

The most frequent charges are LACKS FIRM (manufacturer name and address missing, 1 line) and LACKS N/C (net quantity statement missing, 1 line).

What is Hanzhong TRG Biotech Co., Ltd.'s FEI number?

Hanzhong TRG Biotech Co., Ltd.'s FDA Establishment Identifier (FEI) is 3010549810.

Can shipments from Hanzhong TRG Biotech Co., Ltd. still enter the U.S.?

Shipments of siberian ginseng extract from Hanzhong TRG Biotech Co., Ltd. can be detained without physical examination under Import Alert 54-12; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).